UPS is allocating $48 million to enhance its international cold chain network.

UPS is investing $48 million in 27 temperature-controlled freight cross-dock facilities worldwide to enhance its healthcare logistics network, responding to the growing demand for temperature-sensitive medicines. These facilities are designed for the safe transport of pharmaceuticals requiring strict temperature controls and are compliant with international standards. The global market for temperature-sensitive biologics is projected to grow significantly, necessitating improved logistics systems. UPS aims to address cold-chain failures, which cost the healthcare sector billions annually, while expanding its capabilities through strategic acquisitions and infrastructure investments.